Experts find improved glucose metabolism using subcutaneous insulin

06/9/2011 | HealthDay News

Continuous subcutaneous insulin infusion improved the fasting gluconeogenesis and glycogen cycling in patients with poorly controlled type 1 diabetes, a study in the journal Diabetes found. CSII-treated patients had 70% lower net hepatic glycogen synthesis and 42% higher endogenous glucose production than a control group.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC